Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

Raquel Izumi Biography and Net Worth

Insider of Vincerx Pharma

Raquel Izumi, PhD is the Chief Operations Officer and President of Vincerx and a member of the Vincerx board of directors. Dr Izumi has served as Vincerx’s Chief Operations Officer and as a member Vincerx’s board of directors since March 2019. Before that, Dr Izumi co-founded Acerta Pharma and served as its executive vice president of clinical development from February 2013 to May 2020. Dr Izumi also co-founded Aspire Therapeutics LLC and served as its chief scientific officer from June 2011 to February 2013. Before founding Aspire Therapeutics, Dr Izumi served as senior director of clinical development at Pharmacyclics LLC, a biopharmaceutical company, from February 2010 to May 2011, where she worked on designing and implementing seven clinical studies across various hematologic malignancies (including three studies that garnered breakthrough therapy designation) for the first BTK inhibitor (IMBRUVICA®) to enter clinical trials. Dr Izumi began her research career at Amgen, where she held positions of increasing responsibility and participated in a successful BLA filing and approval for ARANESP®.

Dr Izumi was a Howard Hughes Predoctoral Fellow at the University of California, Los Angeles where she obtained a PhD in microbiology and immunology. She received honors and distinction for her BA in biological sciences from the University of California, Santa Barbara.

What is Raquel E. Izumi's net worth?: The estimated net worth of Raquel E. Izumi is at least $58,427.30 as of December 14th, 2022. Dr. Izumi owns 68,738 shares of Vincerx Pharma stock worth more than $58,427 as of April 20th. This net worth estimate does not reflect any other investments that Dr. Izumi may own. Additionally, Dr. Izumi receives a salary of $551,660.00 as Insider at Vincerx Pharma. Learn More about Raquel E. Izumi's net worth.
How old is Raquel E. Izumi?: Dr. Izumi is currently 54 years old. There are 3 older executives and no younger executives at Vincerx Pharma. The oldest executive at Vincerx Pharma is Mr. Tom C. Thomas J.D., Founder, General Counsel & Chief Legal Officer, who is 65 years old. Learn More on Raquel E. Izumi's age.
What is Raquel E. Izumi's salary?: As the Insider of Vincerx Pharma, Inc., Dr. Izumi earns $551,660.00 per year. The highest earning executive at Vincerx Pharma is Dr. Ahmed M. Hamdy M.D., Founder, Chairman & CEO, who commands a salary of $609,840.00 per year. Learn More on Raquel E. Izumi's salary.
How do I contact Raquel E. Izumi?: The corporate mailing address for Dr. Izumi and other Vincerx Pharma executives is 260 SHERIDAN AVENUE SUITE 400, PALO ALTO CA, 94306. Vincerx Pharma can also be reached via phone at 650-800-6676. Learn More on Raquel E. Izumi's contact information.
Has Raquel E. Izumi been buying or selling shares of Vincerx Pharma?: Raquel E. Izumi has not been actively trading shares of Vincerx Pharma within the last three months. Most recently, on Wednesday, December 14th, Raquel E. Izumi bought 28,738 shares of Vincerx Pharma stock. The stock was acquired at an average cost of $0.88 per share, with a total value of $25,289.44. Following the completion of the transaction, the insider now directly owns 68,738 shares of the company's stock, valued at $60,489.44. Learn More on Raquel E. Izumi's trading history.
Who are Vincerx Pharma's active insiders?: Vincerx Pharma's insider roster includes Laura Bushnell (Director), Ahmed Hamdy (CEO), Raquel Izumi (Insider), Andrew McDonald (Director), Alexander Seelenberger (CFO), and Tom Thomas (Insider). Learn More on Vincerx Pharma's active insiders.
Are insiders buying or selling shares of Vincerx Pharma?: During the last year, Vincerx Pharma insiders bought shares 2 times. They purchased a total of 27,400 shares worth more than $26,030.00. The most recent insider tranaction occured on August, 11th when insider Alexander A Seelenberger bought 10,500 shares worth more than $9,975.00. Insiders at Vincerx Pharma own 20.6% of the company. Learn More about insider trades at Vincerx Pharma.
Information on this page was last updated on 8/11/2023.

Raquel E. Izumi Insider Trading History at Vincerx Pharma

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/14/2022	Buy	28,738	$0.88	$25,289.44	68,738
6/27/2022	Buy	40,000	$1.41	$56,400.00	40,000
8/4/2021	Buy	1,000	$11.96	$11,960.00

Raquel E. Izumi Buying and Selling Activity at Vincerx Pharma

Vincerx Pharma Company Overview

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. It is developing enitociclib, a cyclin-dependent kinase-9 inhibitor that is in Phase 1 clinical trials for treating patients with hematologic malignancies; and VIP236, a small molecule drug conjugate that is in Phase 1 clinical trials to treat solid tumors. The company's preclinical stage product candidates include VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma, Inc. was founded in 2019 is based in Palo Alto, California.

Today's Range

Now: $0.85

$0.83

$0.91

50 Day Range

MA: $4.16

$0.85

$8.06

2 Week Range

Now: $0.85

$0.61

$9.37

Volume

354,883 shs

Average Volume

1,293,431 shs

Market Capitalization

$18.20 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.1

Bitcoin Rockets To Record High But Buy THIS Instead

From Paradigm Press | Ad

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

Raquel Izumi Biography and Net Worth

What is Raquel E. Izumi's net worth?

How old is Raquel E. Izumi?

What is Raquel E. Izumi's salary?

How do I contact Raquel E. Izumi?

Has Raquel E. Izumi been buying or selling shares of Vincerx Pharma?

Who are Vincerx Pharma's active insiders?

Are insiders buying or selling shares of Vincerx Pharma?